University of Miami at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
University of Miami takes part in 2 sessions at ASH 2026 in New Orleans. Its program centres on immune thrombocytopenia and newly diagnosed multiple myeloma. It covers knowledge gaps in understanding and treating immune thrombocytopenia, and bringing new myeloma evidence into community practice.
| Organization | ASH 2026 Attendance |
|---|---|
University of Miami Coral Gables, FL | |
Private research university in the Miami area with the Miller School of Medicine and the UHealth academic health system. | Symposium Fri Dec 11 3:00pm–6:00pm ITP at a Crossroads: Closing Knowledge Gaps in Pathophysiology, Treatment Selection, and Patient-Centred Care Personalizing immune thrombocytopenia care beyond platelet counts, weighing new therapies alongside fatigue, cognition, heavy periods, and quality of life. Symposium Fri Dec 11 11:00am–2:00pm Transforming Care for Newly-Diagnosed Multiple Myeloma: Integrating Evidence-Based Innovation into Community Practice Newly diagnosed multiple myeloma care in community clinics, using frailty assessment, dose adjustment to protect quality of life, and new drug formulations. |
Instantly find 20 buyers from University of Miami
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction